AQUAVAC® Vibrio Pasteurella


Diseases Treated

AQUAVAC® Vibrio Pasteurella

Inactivated, injection administered vaccine for the prevention of vibriosis and pasteurellosis in European sea bass (Dicentrarchus labrax).

Key Features

  • Contains inactivated cultures of (Listonella) Vibrio anguillarum (biotype I and II) and Photobacterium damsela (subsp piscicida) carefully selected for their strong immune response and broad-spectrum protection

  • Demonstrated protection against significant Vibrio anguillarum biotype I and biotype II and Photobacterium damsela isolates causing problems for sea bass farming in the Mediterranean region

  • Established bivalent vaccine used by farmers needing to protect against both pasteuerellosis and vibriosis in a single vaccination

Key Benefits

  • Increased survival in juvenile sea bass

  • Reduces incidence and severity of both vibriosis and pasteurellosis

  • Injection vaccine for the control of severe endemic disease

  • Forms part of the Total Protection Strategy against both vibriosis and pasteurellosis

< More vaccines

This website contains information on veterinary pharmaceutical and biological products based on international registration dossiers. The site may refer to products that are either not available in your country or are marketed under a different tradename. In addition, the safety and efficacy data and the withholding periods for a specific product may be different depending on local regulations. Please consult your veterinarian for further information.